Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):159-162
This paper considers safety issues associated with medical therapy of sexually transmitted diseases (STDs). Data supporting safety of azithromycin as part of treatment regimens for infections due to chlamydia and mycoplasma are provided. Possible triggers of drug-induced liver injury when administering antimicrobial therapy of STDs are also discussed.